TrialNature communications2025

Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial.

S L Aronson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.